Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity...

19

Transcript of Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity...

Page 1: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 2: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 3: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 4: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 5: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 6: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 7: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 8: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 9: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 10: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 11: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 12: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 13: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 14: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 15: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 16: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 17: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 18: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients
Page 19: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016  · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients